"epidermal growth factor receptors" trang 12 - tải miễn phí từ tailieunhanh
EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
10    72    1
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
16    49    1
Computational analyses of curcuminoid analogs against kinase domain of HER2

Computational analyses of curcuminoid analogs against kinase domain of HER2
13    24    1
Coupled mutation finder: A new entropybased method quantifying phylogenetic noise for the detection of compensatory mutations

Coupled mutation finder: A new entropybased method quantifying phylogenetic noise for the detection of compensatory mutations
12    25    1
Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety

Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety
13    22    1
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
9    42    1
Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease

Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease
10    27    1
Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer

Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer
9    57    1
A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung

A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung
4    32    1
Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR

Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR
11    48    1
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment

Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
7    24    1
Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment

Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment
6    31    1
Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer
7    39    1
Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies
9    44    1
Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations

Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations
13    20    1
Genome-wide association study reveals the genetic architecture of root hair length in maize

Genome-wide association study reveals the genetic architecture of root hair length in maize
11    34    1
The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells

The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells
9    62    1
Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations
8    23    1
REMARRY and PURSUIT trials: Liquid biopsyguided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

REMARRY and PURSUIT trials: Liquid biopsyguided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer
6    55    1
Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma

Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma
11    52    1